Larry Keeley, an innovation expert and partner at Monitor, explains how Kodak’s famous failure to enter digital photography quickly can be a useful lesson for executives looking to innovate now. He writes that a new form of strategic thinking, convergences, “gives leaders a deeper sense of the interdependencies that connect firms, products, systems and services in new ecosystems” and reveals emerging opportunities, typically at the junction of new technologies and customer behaviors.

In these video highlights from Monitor’s recent webcast, “Improving Innovation Returns Through Business Model Innovation,” Monitor thought leaders discuss how analytic tools can provide better decision-making insights to help executives vastly improve their innovation success rates and ensure their business model investments generate bigger returns.

Many companies experience cycles in which revenue growth and cost cutting alternate in focus. While these cycles are understandable, they often damage long-term profitability. In this article, Monitor's Robert Browne, Josh Lee, Mike Standing and Lisa S. Thompson present the Delivering Measurable Results approach, which helps firms escape these cycles of revenue growth and cost cutting by developing programs that can sustainably improve their margins.

The benefits of having an entrepreneurial culture are clear—it leads to more effective and loyal employees, higher levels of innovation, and faster reaction times, just to name a few. But entrepreneurial environments aren’t just for small start-ups in new markets—even large companies in existing business sectors can create an entrepreneurial environment by employing five key enablers, explain Monitor’s Francesco Fazio, Joel Finlayson and Neil Pearse in this article.

Determining and communicating the economic value of a product is one of the major strategic imperatives for the pharmaceutical industry as regulatory agencies move toward comparative effectiveness approaches and value-based pricing. Monitor’s Comparative Clinical and Economic Value (CCEV™) approach enables companies to apply economic-value-based thinking across the entire development, commercialization and health care delivery process.

At a time when the global life sciences and pharmaceutical industries are beset by major challenges, including patent cliffs, skyrocketing costs of drug approvals and failures in key trials, China is spending billions of dollars on life sciences initiatives. This report finds China poised to become the global leader in life science discovery and innovation within the decade.

The slowed growth experienced by the German medical devices market, a large, global industry with a history of innovation and profit, requires targeted and pragmatic responses from industry leaders. In this article, the authors explain how companies can use value-based pricing systems to optimize their bottom line and avoid being caught in the downward spiral that comes with reactionary price cutting.

The world’s rapidly growing megacities represent significant opportunities for companies seeking new markets and justify a unique approach to an important source of potential growth. In this article, Jennifer Lacks Kaplan and Mark Pocharski explain what it takes for companies to build winning strategies to take advantage of this growth opportunity.

In this presentation to the Estonian Development Fund, Monitor co-founder Joseph Fuller explains the necessary elements for nations working on a vision for economic development drawing on his experience working with more than 35 countries creating national and regional economic strategies.

In a new report tracking sovereign wealth fund investments, Monitor Group and Fondazione Eni Enrico Mattei found that the funds had adapted to the global economic downturn by realigning investment strategies with long-term goals and pursuing joint investments to share risk.